KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Treasury Shares (2018 - 2025)

Elanco Animal Health's Treasury Shares history spans 7 years, with the latest figure at $5.5 million for Q4 2025.

  • For Q4 2025, Treasury Shares rose 120.0% year-over-year to $5.5 million; the TTM value through Dec 2025 reached $5.5 million, up 120.0%, while the annual FY2025 figure was $5.5 million, 120.0% up from the prior year.
  • Treasury Shares for Q4 2025 was $5.5 million at Elanco Animal Health, up from $2.5 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $5.5 million in Q4 2025 and bottomed at $1.0 million in Q4 2021.
  • The 5-year median for Treasury Shares is $2.0 million (2022), against an average of $2.5 million.
  • The largest annual shift saw Treasury Shares crashed 35.0% in 2023 before it skyrocketed 120.0% in 2025.
  • A 5-year view of Treasury Shares shows it stood at $1.0 million in 2021, then skyrocketed by 100.0% to $2.0 million in 2022, then plummeted by 35.0% to $1.3 million in 2023, then surged by 92.31% to $2.5 million in 2024, then soared by 120.0% to $5.5 million in 2025.
  • Per Business Quant, the three most recent readings for ELAN's Treasury Shares are $5.5 million (Q4 2025), $2.5 million (Q4 2024), and $1.3 million (Q4 2023).